Clark Kevin Cronin 4

What Happened Kevin Cronin, CEO of Cross Country Healthcare, received a grant of 138,963 restricted shares on March 31, 2026. The shares were granted at a $0.00 per-share acquisition price (no cash paid at grant). This was an award/compensation grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31; Form 4 filed 2026-04-02 (appears timely).
• Grant details: 138,963 restricted shares, acquisition price $0.00, total cash consideration $0.
• Vesting: Shares vest in three substantially equal installments on 2027-03-31, 2028-03-31 and 2029-03-31 (Footnote F1).
• Ownership after transaction: Not specified in the provided summary.
• Footnote on spouse holdings: Footnote F2 notes shares held by Mr. Cronin's spouse; he disclaims beneficial ownership except to the extent of any pecuniary interest.
• Transaction type: Award/Grant (code A) — typically part of executive compensation.

Context This was a compensation award, which is common for executives and does not reflect an open-market trading decision. Restricted shares generally vest over time and may carry forfeiture or other conditions until vesting; they are not immediate cash or a direct market purchase.